POSA208 Recognising Value of Multi-Indication Therapies: Can Pricing by Indication Benefit Payers As Well As Patients? Results of a Modelling Exercise
Abstract
Authors
A Cole M Neri A Horsfield M Conge G Cookson
A Cole M Neri A Horsfield M Conge G Cookson
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now